Shares of MediPharm Labs Corp. (TSE:LABS – Get Free Report) traded up 7.7% on Thursday . The company traded as high as C$0.08 and last traded at C$0.07. 713,415 shares changed hands during mid-day trading, an increase of 107% from the average session volume of 344,238 shares. The stock had previously closed at C$0.07.
MediPharm Labs Price Performance
The stock’s 50 day moving average price is C$0.07 and its 200-day moving average price is C$0.07. The company has a quick ratio of 3.10, a current ratio of 3.11 and a debt-to-equity ratio of 5.90. The stock has a market capitalization of C$26.72 million, a PE ratio of -1.63 and a beta of 0.88.
MediPharm Labs Company Profile
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
Recommended Stories
- Five stocks we like better than MediPharm Labs
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- What Is WallStreetBets and What Stocks Are They Targeting?
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- CVS Health: Earnings Beat Ignites Stock Rally
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
